BioTelemetry, Inc.
BEAT
BEAT was delisted on the 8th of February, 2021.
281 hedge funds and large institutions have $1.78B invested in BioTelemetry, Inc. in 2018 Q4 according to their latest regulatory filings, with 60 funds opening new positions, 94 increasing their positions, 96 reducing their positions, and 32 closing their positions.
88% more first-time investments, than exits
New positions opened: 60 | Existing positions closed: 32
43% more call options, than puts
Call options by funds: $23.9M | Put options by funds: $16.8M
10% more funds holding
Funds holding: 256 → 281 (+25)
2% less repeat investments, than reductions
Existing positions increased: 94 | Existing positions reduced: 96
7% less capital invested
Capital invested by funds: $1.91B → $1.78B (-$126M)
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$50.2M |
| 2 |
Renaissance Technologies
New York
|
+$15.8M |
| 3 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
+$11.5M |
| 4 |
Legal & General Group
London,
United Kingdom
|
+$8.97M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$8.88M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$16.6M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$15.6M |
| 3 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$13.8M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$10.9M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$9.36M |
BEAT Hedge Fund Activity: Q4 2018 in Review
281 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q4 2018, worth a combined $1.78B — down 6.6% from $1.91B a quarter earlier.
Buyers outnumbered sellers: 60 funds opened new BEAT positions and 32 closed out — a net gain of 28 holders — while 94 added to existing stakes and 96 trimmed.
The largest buyer was Vanguard Group, adding an estimated $50.2M. The largest seller was Macquarie Group, cutting an estimated $16.6M.
- 281 institutional investors held BioTelemetry, Inc. (BEAT) as of Q4 2018, up from 256 in Q3 2018.
- Funds reported $1.78B of BioTelemetry, Inc. stock for Q4 2018, down 6.6% quarter-over-quarter.
- 60 funds opened new BioTelemetry, Inc. positions in Q4 2018 and 32 closed out, a net change of +28 holders.
- The largest BioTelemetry, Inc. buyer in Q4 2018 was Vanguard Group, an estimated $50.2M added.
- The largest BioTelemetry, Inc. seller in Q4 2018 was Macquarie Group, an estimated $16.6M sold.
Based on aggregated 13F filings for Q4 2018.